Specialized [18F]CFA PET radiotracer showing persistent dCK activity in a tumor-bearing mouse following KRASi treatment (left), followed by complete blockade of tumor dCK activity after TRE-515 treatment (right).
Specialized [18F]CFA PET radiotracer showing persistent dCK activity in a tumor-bearing mouse following KRASi treatment (left), followed by complete blockade of tumor dCK activity after TRE-515 treatment (right).